跳至主要内容
临床试验/NCT06498037
NCT06498037招募中4 期

Optimizing Subcutaneous FEntanyl titRation: RApid Achievement of Adequate Exposure When Treating Cancer-Related paIn.

Erasmus Medical Center1 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2024年2月23日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
招募中
入组人数
45
试验地点
1
主要终点
Primary endpoint of this study is to prove the non-inferiority in fentanyl plasma concentrations 12 hours after dose augmentation compared to 48 hours after dose augmentation within each patient using a bioequivalence approach

研究概览

简要总结

The primary objective is to evaluate the effect of loading boluses when dose incresaing treatment with SC fentanyl in patients with cancer. The primary endpoint of this study is to prove the non-inferiority of fentanyl plasma concentrations 12 hours after dose augmentation compared to 48 hours after dose augmentation within each patient.

Patients will be treated with additional loading boluses and plasma-PK samples will be obtained.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 120 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥18 years;
  • Able to understand the written information and able to give informed consent.
  • Current or planned treatment with SC fentanyl for cancer-related pain

排除标准

  • Pregnancy or/ and breastfeeding
  • Other ways of using fentanyl (sublingual, nasal spray and oromucosal)
  • Liver function CPS B or C
  • The use of strong CYP3A4 inhibitors of inducers [9]
  • Presence of somnolence, respiratory depression or CTCAE grade 2 adverse events.

研究组 & 干预措施

Intervention arm

Experimental

Patients are given loading doses when dose-increasing fentanyl. The concentrations at 12 and 48 hours after dose increase will be compared

干预措施: Fentanyl (Drug)

结局指标

主要结局

Primary endpoint of this study is to prove the non-inferiority in fentanyl plasma concentrations 12 hours after dose augmentation compared to 48 hours after dose augmentation within each patient using a bioequivalence approach

时间窗: 48 hours after dose increase

Using a paired t-test the geometric mean of the ratio of the two fentanyl plasma concentrations will be compared. The 90% confidence interval of the geomteric mean should fall within the range of 80 - 125%.

次要结局

  • Investigate the safety of the loading bolus strategy by assessing whether CTCAE grade III or higher occur as a consequence of the fentanyl loading boluses.(up to 48 hours after dose increase)
  • Describe the course of patient reported pain intensity in the 48 hours following the loading boluses.(up to 48 hours after dose increase)
  • Accurately assess the rate of fentanyl absorption after SC fentanyl administered as a bolus.(up to 48 hours after dose increase)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Prof. R.H.J. Mathijssen, MD, PhD

prof.R.H.J. Mathijssen

Erasmus Medical Center

研究点 (1)

Loading locations...

相似试验